3
Clinical Trials associated with VV913 / Not yet recruitingEarly Phase 1 Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules in Chinese Healthy Participants
This study is a single-center, randomized, double-blind, placebo-controlled, dose-escalation trial to assess the safety, tolerability, pharmacokinetics (PK) of multiple doses of VV913 in Chinese healthy adult participants.
/ Not yet recruitingPhase 1 A Phase I Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics of a Single Oral Dose of VV913 Capsules in Chinese Healthy Participants
This is a randomized, double-blind, placebo-controlled, single ascending-dose study to evaluate the safety, tolerability and pharmacokinetics characteristics of VV913 Capsules in healthy adults.
/ Not yet recruitingPhase 1 在健康试验参与者中评价食物对VV913胶囊药代动力学的影响
[Translation] Evaluate the effects of food on the pharmacokinetics of VV913 capsules in healthy trial participants.
评价高脂餐和标准餐饮食对中国健康试验参与者口服VV913胶囊后药代动力学(PK)和安全性的影响。
[Translation] To evaluate the effects of high-fat meals and standard meals on the pharmacokinetics (PK) and safety of VV913 capsules after oral administration to Chinese healthy trial participants.
100 Clinical Results associated with VV913
100 Translational Medicine associated with VV913
100 Patents (Medical) associated with VV913
100 Deals associated with VV913